In fact, gene therapy with SN has been demonstrated to induce therapeutic angiogenesis via a nitric oxide-dependent mechanism, and benefit Apo E-/- mice following hind-limb ischemia without influencing atherosclerosis [17, 34]. The gene discussed is APOE; the disease is atherosclerosis.